Reports - Genetic Testing Market
HealthcareGenetic Testing Market
Genetic Testing Market: Solutions, Growth & Trends | 2025-2035 by Test Type (Diagnostic Testing, Predictive and Presymptomatic Testing, Carrier Testing, Prenatal and Newborn Screening, Pharmacogenomic Testing, Other) by Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Chromosomal Microarray, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing) by Application (Oncology, Rare Diseases, Neurological Disorders, Cardiovascular Diseases, Genetic Disease Risk Assessment, Ancestry Testing, Paternity Testing, Other) by End-User (Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Direct-to-Consumer (DTC) Testing Services, Forensic Laboratories, Other) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Genetic Testing Market - Segment Analysis
1. Overview
2. Global Genetic Testing Market, 2021 - 2034 (USD Million)
3. Global Genetic Testing Market - by Test Type
3.1. By Diagnostic Testing
3.2. By Predictive and Presymptomatic Testing
3.3. By Carrier Testing
3.4. By Prenatal and Newborn Screening
3.5. By Pharmacogenomic Testing
3.6. By Other
4. Global Genetic Testing Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Polymerase Chain Reaction (PCR)
4.3. By Chromosomal Microarray
4.4. By Fluorescence In Situ Hybridization (FISH)
4.5. By Sanger Sequencing
5. Global Genetic Testing Market - by Application
5.1. By Oncology
5.2. By Rare Diseases
5.3. By Neurological Disorders
5.4. By Cardiovascular Diseases
5.5. By Genetic Disease Risk Assessment
5.6. By Ancestry Testing
5.7. By Paternity Testing
5.8. By Other
6. Global Genetic Testing Market - by End-User
6.1. By Hospitals and Clinics
6.2. By Diagnostic Laboratories
6.3. By Research Institutes
6.4. By Direct-to-Consumer (DTC) Testing Services
6.5. By Forensic Laboratories
6.6. By Other
7. Global Genetic Testing Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Genetic Testing Market - Segment Analysis
1. Overview
2. North America Genetic Testing Market, 2021 - 2034 (USD Million)
3. North America Genetic Testing Market - by Test Type
3.1. By Diagnostic Testing
3.2. By Predictive and Presymptomatic Testing
3.3. By Carrier Testing
3.4. By Prenatal and Newborn Screening
3.5. By Pharmacogenomic Testing
3.6. By Other
4. North America Genetic Testing Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Polymerase Chain Reaction (PCR)
4.3. By Chromosomal Microarray
4.4. By Fluorescence In Situ Hybridization (FISH)
4.5. By Sanger Sequencing
5. North America Genetic Testing Market - by Application
5.1. By Oncology
5.2. By Rare Diseases
5.3. By Neurological Disorders
5.4. By Cardiovascular Diseases
5.5. By Genetic Disease Risk Assessment
5.6. By Ancestry Testing
5.7. By Paternity Testing
5.8. By Other
6. North America Genetic Testing Market - by End-User
6.1. By Hospitals and Clinics
6.2. By Diagnostic Laboratories
6.3. By Research Institutes
6.4. By Direct-to-Consumer (DTC) Testing Services
6.5. By Forensic Laboratories
6.6. By Other
Chapter 5 Europe Genetic Testing Market - Segment Analysis
1. Overview
2. Europe Genetic Testing Market, 2021 - 2034 (USD Million)
3. Europe Genetic Testing Market - by Test Type
3.1. By Diagnostic Testing
3.2. By Predictive and Presymptomatic Testing
3.3. By Carrier Testing
3.4. By Prenatal and Newborn Screening
3.5. By Pharmacogenomic Testing
3.6. By Other
4. Europe Genetic Testing Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Polymerase Chain Reaction (PCR)
4.3. By Chromosomal Microarray
4.4. By Fluorescence In Situ Hybridization (FISH)
4.5. By Sanger Sequencing
5. Europe Genetic Testing Market - by Application
5.1. By Oncology
5.2. By Rare Diseases
5.3. By Neurological Disorders
5.4. By Cardiovascular Diseases
5.5. By Genetic Disease Risk Assessment
5.6. By Ancestry Testing
5.7. By Paternity Testing
5.8. By Other
6. Europe Genetic Testing Market - by End-User
6.1. By Hospitals and Clinics
6.2. By Diagnostic Laboratories
6.3. By Research Institutes
6.4. By Direct-to-Consumer (DTC) Testing Services
6.5. By Forensic Laboratories
6.6. By Other
Chapter 6 Asia Pacific Genetic Testing Market - Segment Analysis
1. Overview
2. Asia Pacific Genetic Testing Market, 2021 - 2034 (USD Million)
3. Asia Pacific Genetic Testing Market - by Test Type
3.1. By Diagnostic Testing
3.2. By Predictive and Presymptomatic Testing
3.3. By Carrier Testing
3.4. By Prenatal and Newborn Screening
3.5. By Pharmacogenomic Testing
3.6. By Other
4. Asia Pacific Genetic Testing Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Polymerase Chain Reaction (PCR)
4.3. By Chromosomal Microarray
4.4. By Fluorescence In Situ Hybridization (FISH)
4.5. By Sanger Sequencing
5. Asia Pacific Genetic Testing Market - by Application
5.1. By Oncology
5.2. By Rare Diseases
5.3. By Neurological Disorders
5.4. By Cardiovascular Diseases
5.5. By Genetic Disease Risk Assessment
5.6. By Ancestry Testing
5.7. By Paternity Testing
5.8. By Other
6. Asia Pacific Genetic Testing Market - by End-User
6.1. By Hospitals and Clinics
6.2. By Diagnostic Laboratories
6.3. By Research Institutes
6.4. By Direct-to-Consumer (DTC) Testing Services
6.5. By Forensic Laboratories
6.6. By Other
Chapter 7 Latin America Genetic Testing Market - Segment Analysis
1. Overview
2. Latin America Genetic Testing Market, 2021 - 2034 (USD Million)
3. Latin America Genetic Testing Market - by Test Type
3.1. By Diagnostic Testing
3.2. By Predictive and Presymptomatic Testing
3.3. By Carrier Testing
3.4. By Prenatal and Newborn Screening
3.5. By Pharmacogenomic Testing
3.6. By Other
4. Latin America Genetic Testing Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Polymerase Chain Reaction (PCR)
4.3. By Chromosomal Microarray
4.4. By Fluorescence In Situ Hybridization (FISH)
4.5. By Sanger Sequencing
5. Latin America Genetic Testing Market - by Application
5.1. By Oncology
5.2. By Rare Diseases
5.3. By Neurological Disorders
5.4. By Cardiovascular Diseases
5.5. By Genetic Disease Risk Assessment
5.6. By Ancestry Testing
5.7. By Paternity Testing
5.8. By Other
6. Latin America Genetic Testing Market - by End-User
6.1. By Hospitals and Clinics
6.2. By Diagnostic Laboratories
6.3. By Research Institutes
6.4. By Direct-to-Consumer (DTC) Testing Services
6.5. By Forensic Laboratories
6.6. By Other
Chapter 8 Middle East & Africa Genetic Testing Market - Segment Analysis
1. Overview
2. Middle East & Africa Genetic Testing Market, 2021 - 2034 (USD Million)
3. Middle East & Africa Genetic Testing Market - by Test Type
3.1. By Diagnostic Testing
3.2. By Predictive and Presymptomatic Testing
3.3. By Carrier Testing
3.4. By Prenatal and Newborn Screening
3.5. By Pharmacogenomic Testing
3.6. By Other
4. Middle East & Africa Genetic Testing Market - by Technology
4.1. By Next-Generation Sequencing (NGS)
4.2. By Polymerase Chain Reaction (PCR)
4.3. By Chromosomal Microarray
4.4. By Fluorescence In Situ Hybridization (FISH)
4.5. By Sanger Sequencing
5. Middle East & Africa Genetic Testing Market - by Application
5.1. By Oncology
5.2. By Rare Diseases
5.3. By Neurological Disorders
5.4. By Cardiovascular Diseases
5.5. By Genetic Disease Risk Assessment
5.6. By Ancestry Testing
5.7. By Paternity Testing
5.8. By Other
6. Middle East & Africa Genetic Testing Market - by End-User
6.1. By Hospitals and Clinics
6.2. By Diagnostic Laboratories
6.3. By Research Institutes
6.4. By Direct-to-Consumer (DTC) Testing Services
6.5. By Forensic Laboratories
6.6. By Other
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Abbott Laboratories
2. Danaher Corporation (Cepheid Inc.)
3. Illumina Inc.
4. BioRad Laboratories Inc.
5. F. Hoffmann-La Roche Ltd
6. 23andMe Inc.
7. Myriad Genetics Inc.
8. DiaSorin S.p.A. (Luminex Corporation)
9. PerkinElmer Inc.
10. Quest Diagnostics Incorporated
11. Eurofins Scientific
12. Qiagen N.V.
13. Thermo Fisher Scientific
14. Invitae Corporation
15. Agilent Technologies.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By